3
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Identification of a Novel NF-κB p50-Related Protein in B Lymphocytes

, &
Pages 7089-7097 | Received 08 Apr 1996, Accepted 11 Sep 1996, Published online: 29 Mar 2023
 

Abstract

In most cell types other than mature B lymphocytes and macrophages, the transcription factor NF-kB remains in an inactive form in the cytosol by being bound to the inhibitory proteins IκBα and IκBβ. To investigate the regulation of constitutively active NF-κB in B lymphocytes, we have examined the composition of Rel protein complexes in different mouse B-cell lines. As reported previously, the constitutively active complex in mature B cells was predominantly p50:c-Rel. However, the κB binding complex in the plasmacytomas that were examined lacked c-Rel and instead contained only a p50-related protein. This p50-related protein (p55) cross-reacts with three different p50 antisera, exists in both the cytosol and the nucleus, and is the protein that binds to κB sites in plasma cells. Transfection of reporter constructs into plasma cells indicates that the p55 complex is also transcriptionally active. The p55 protein can be detected in splenocytes from mice lacking the p105/p50 gene, and therefore it appears to be the product of a distinct gene. The implications of the existence of a NF-κB p50-related protein in plasma cells that is capable of binding to κB sites and activating transcription are discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.